BetaThis search tool is in development. Find out more.
Find thousands of books, manuscripts, visual materials and unpublished archives from our collections, many of them with free online access.
Digital Images

Biosimilars

Odra Noel

Available online

view Biosimilars

License

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
You can use this work for any purpose, as long as it is not primarily intended for or directed to commercial advantage or monetary compensation. You should also provide attribution to the original work, source and licence.
Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) terms and conditions https://creativecommons.org/licenses/by-nc/4.0

Selected images from this work


About this work

Description

Biopharmaceuticals are a very important part of the therapeutic options in many diseases. They are made by, or derived from, living organisms using biotechnology. But they are also very expensive drugs. Biosimilar are the generally cheaper versions of existing biopharmaceuticals that are made after the market exclusivity rights of the original biopharmaceutical has expired. They are properly licensed, with proven comparable quality, efficacy and safety. Within the round pink window, the purple coloured molecule near the top is the originator. The orange background molecule just below is the first biosimilar. The other orange one is the second biosimilar. The other purple background molecule lower down is also the originator, after a manufacture change was implemented.

Contributors


Permanent link


We’re improving the information on this page. Find out more.